✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd.

AMBALALSA

Market Cap
₹272 Cr.
P/E
55.20

Ambalal Sarabhai Enterprises Ltd.

  • Ambalal Sarabhai Ent
  • Balaxi Pharma.
  • Gennex Lab
FAQs on Ambalal Sarabhai Enterprises Ltd. Shareprice

Ambalal Sarabhai Ent has given lower returns compared to its competitors.
Ambalal Sarabhai Ent has grown at ~11.22% over the last 2yrs while peers have grown at a median rate of 21.53%

Ambalal Sarabhai Ent is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Ambalal Sarabhai Ent is 55.2, while 3 year average PE is 30.44.
Also latest EV/EBITDA of Ambalal Sarabhai Ent is 38.25 while 3yr average is 41.11.

View FAQ's On Business
Growth Table
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Balance Sheet
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Cash Flow
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Quarterly Results
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Ambalal Sarabhai Enterprises Ltd. Financials

Balance sheet of Ambalal Sarabhai Ent is moderately strong.

Yes, The net debt of Ambalal Sarabhai Ent is increasing.
Latest net debt of Ambalal Sarabhai Ent is ₹37.07 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹20.67 Crs.

No, profit is decreasing.
The profit of Ambalal Sarabhai Ent is ₹4.29 Crs for TTM, ₹5.68 Crs for Mar 2024 and ₹11.45 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ambalal Sarabhai Ent latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech